DocuSign (DOCU) Expected to Announce Earnings on Thursday

DocuSign (NASDAQ:DOCU) is anticipated to release its earnings data after the market closes on Thursday, March 13th. Analysts expect DocuSign to post earnings of $0.84 per share and revenue of $760.94 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

DocuSign Stock Performance

NASDAQ DOCU opened at $82.36 on Thursday. DocuSign has a twelve month low of $48.70 and a twelve month high of $107.86. The stock has a market capitalization of $16.64 billion, a PE ratio of 16.98, a P/E/G ratio of 6.94 and a beta of 1.02. The stock has a 50-day simple moving average of $89.64 and a 200 day simple moving average of $78.28.

Analyst Ratings Changes

Several research firms recently weighed in on DOCU. Robert W. Baird boosted their price objective on DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. UBS Group boosted their price target on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Citigroup boosted their price target on DocuSign from $87.00 to $113.00 and gave the company a “buy” rating in a research note on Friday, December 6th. Royal Bank of Canada restated a “sector perform” rating and set a $90.00 price target (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Finally, JPMorgan Chase & Co. boosted their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, DocuSign presently has a consensus rating of “Hold” and an average price target of $92.45.

Insider Activity

In related news, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the sale, the director now directly owns 7,736 shares in the company, valued at $731,825.60. This represents a 6.46 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the sale, the director now owns 906,430 shares in the company, valued at approximately $87,959,967.20. This trade represents a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 686,010 shares of company stock worth $66,102,694. Company insiders own 1.66% of the company’s stock.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.